Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"
Paolo A Ascierto, Antonio M Grimaldi, Nicolas Acquavella, Lorenzo Borgognoni, Luana Calabro, Natale Cascinelli, Alessandra Cesano, Michele Del Vecchio, Alexander M Eggermont, Mark Faries, Soldano Ferrone, Bernard A Fox, Thomas F Gajewski, Jerome Galon, Sacha Gnjatic, Helen Gogas, Mohammed Kashani-Sabet, Howard L Kaufman, James Larkin, Roger S Lo Show all
JOURNAL OF TRANSLATIONAL MEDICINE | BMC | Published : 2013
Recent insights into the genetic and somatic aberrations have initiated a new era of rapidly evolving targeted and immune-based treatments for melanoma. After decades of unsuccessful attempts to finding a more effective cure in the treatment of melanoma now we have several drugs active in melanoma. The possibility to use these drugs in combination to improve responses to overcome the resistance, to potentiate the action of immune system with the new immunomodulating antibodies, and identification of biomarkers that can predict the response to a particular therapy represent new concepts and approaches in the clinical management of melanoma. The third "Melanoma Research: "A bridge from Naples ..View full abstract
Awarded by NATIONAL CANCER INSTITUTE
The meeting was supported by Fondazione Melanoma Onlus and the Society of ImmunoTherapy of Cancer (SITC). A special thanks to 3P Solution of Napoli for their support and cooperation in organizing the meeting and to Michael Hoetzel for providing us with the group picture from the meeting. Sacha Gnjatic would like to acknowledge the Cancer Research Institute/Ludwig Institute for Cancer Research Cancer Vaccine Collaborative for grant support. All Authors would like to dedicate this manuscript to the memory of Natale Cascinelli who devoted his life to the research and care of melanoma patients and was an example for all of us.